Safety of dobutamine-atropine stress myocardial perfusion scintigraphy

Journal of Nuclear Medicine

Volumn 39, Issue 10, 1998, Pages 1662-1666

  Elhendy, Abdou ^a   Valkema, Roelf ^a   Van Domburg, Ron T ^a   Bax, Jeroen J ^a   Nierop, Peter R ^a   Cornel, Jan H ^a   Geleijnse, Marcel L ^a   Reijs, Ambroos E M ^a   Krenning, Eric P ^a   Roelandt, Jos R T C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Dobutamine; Myocardial perfusion; Safety

Indexed keywords

ATROPINE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METOPROLOL; TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGE; AGED; ARTICLE; CORONARY ARTERY DISEASE; DRUG SAFETY; EXERCISE TEST; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE;

ATROPINE; CORONARY DISEASE; DOBUTAMINE; FEASIBILITY STUDIES; FEMALE; HEART; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RISK FACTORS; SAFETY; TACHYCARDIA; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031687306     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kolters TS, Diamond GA. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease [Review]. Ann Intern Med 1990;113:684-702.
2. Lette J, Tatum JL, Fraser S, Miller DD, Watson DD, Heller G. Safety of dipyridamole testing in 73,806 patients: the multicenter dipyridamole safety study. J Nucl Cardiol 1995;2:3-17.
3. Cerqucria MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Investigations of the multicenter adenoscan trials. Safety profile of adenosinc stress perfusion imaging: results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994;23:384-389.
4. Dakik HB, Vempathy H, Verani MS. Tolerance, haemodynamic changes and safety of dobutamine stress perfusion imaging. J Nucl Cardiol 1996;3:410-414.
5. Pennell DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991;18:1471-1479.
6. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583-590.
7. Marwick TH, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography, scintigraphy or both? J Am Coll Cardiol 1993;22:159-167.
8. 99mTc-sestamibi SPECT myocardial perfusion scintigraphy in the prediction of restenosis after percutaneous transluminal coronary angioplasty in patients unable to perform exercise stress test. Nucl Med Commun 1997;18:122-128.
9. 201Tl SPECT imaging for the assessment of peri-infarction and remote myocardial ischemia. J Nucl Med 1996;37:1951-1956.
10. 99mTc-sestamibi SPECT myocardial perfusion scintigraphy in predicting the extent of coronary artery disease in patients with healed myocardial infarction. Am J Cardiol 1997;79:7-12.
11. 99mTc-sestamibi perfusion scintigraphy for evaluation of ischemic heart disease J Am Coll Cardiol 1996;28:447-454.
12. Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic significance of normal dobutamine atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 1996;77:1057-1061.
13. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain: echocardiography, perfusion scintigraphy or both? Circulation 1997;96:137-147
14. Meters H, Sawada SG, Ryan T, et al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography experience in 1118 patients. Circulation 1993;88:15-19.
15. Cornel JH, Balk AHMM, Arnese M, et al. Safety and feasibility of dobutamineatropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996;9:27-32.
16. Poldermans D, Fioretti PM, Boersma E, et al. Safety of dobutamine atropine stress echocardiography in patients with suspected coronary artery disease. Am J Cardiol 1994;73:456-459.
17. Picano E, Mathias Jr W, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective multicenter study. Lancet 1994;344:1190-1192.
18. Secknus M, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years. J Am Coll Cardiol 1997;29:1234-1240.
19. Elhendy A, van Domburg RT, Roelandt JRTC, Geleijnse ML, Ibrahim MM, Fioretti PM. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension 1997;29:1232-1239.
20. Elhendy A, Geleijnse ML, Roelandt JRTC, et al. Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischemia assessed by quantitative MIBI SPECT imaging. Eur J Nucl Med 1996;23:1354-1360.
21. Marcovitz PA, Bach DS, Mathias W, Shayana V, Armstrong WF. Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. J Am Coll Cardiol 1993;21:1080-1086.
22. Elhendy A, Geleijnse ML, Roelandt JRTC, et al. Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress. J Am Coll Cardiol 1996;27:323-329.
23. 99mTc-sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. Am J Cardiol 1997;79:1031-1035.
24. Rostagno C, Paladini B, Taddei T, et al. Out-of-hospital symptomatic supraventricular tachycardia. Epidemiological aspects derived from 10 years experience of the Florence Mobile Coronary Care Unit. G Ital Cardiol 1993;23:549-562.
25. Maurer MS, Shafrin EA, Fleg JL. Prevalence and prognostic significance of exercise-induced supraventricular tachycardia in apparently healthy volunteers. Am J Cardiol 1995;75:788-792.
26. Elhendy A, Geleijnse ML, van Domburg RT, et al. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997;80:1414-1481.
27. 99mTc hexakis 2-methoxyisobutyl isonitrile SPECT for estimating the extent of myocardial ischemia and infarction in coronary artery disease. Am J Cardiol 1990;66:1438-1444.
28. 99mTc-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 1994;35:681-688.